Mi Wang
- Pharmaceutical Science top 0.5%
- Hematology top 2%
- Multiple Myeloma Research and Treatments 11
- Molecular Biology top 2%
- Protein Degradation and Inhibitors 23
- Ubiquitin and proteasome pathways 17
- Oncology top 2%
- Peptidase Inhibition and Analysis 13
- Immunology top 5%
-
- Veterinary medicine and infectious diseases 12
-
- Coccidia and coccidiosis research 12
-
- Nuclear Materials and Properties 8
-
- Synthesis and Biological Evaluation 8
- Co-authors
- Shaomeng WangChao‐Yie YangJeanne A. StuckeyKrishnapriya ChinnaswamyWeisan PanDonna McEachernNing LiLiu Liu
- Journals
- Journal of Medicinal Chemistry (19 papers)Journal of Colloid and Interface Science (4 papers)Frontiers in Psychiatry (4 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Mi Wang
192 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pharmaceutical Science 444
- Hematology 591
- Molecular Biology 3.0k
- Oncology 1.1k
- Immunology 600
Countries citing papers authored by Mi Wang
This map shows the geographic impact of Mi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Wang more than expected).
Fields of papers citing papers by Mi Wang
This network shows the impact of papers produced by Mi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Wang. The network helps show where Mi Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 40 | |
| 8 | 2023 | 25 | |
| 9 | 2023 | 28 | |
| 10 | 2023 | 14 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 50 | |
| 15 | 2022 | 12 | |
| 16 | 2021 | 17 | |
| 17 | 2021 | 26 | |
| 18 | 2021 | 31 | |
| 19 | Prokaryotic expression of N protein of caprine parainfluenza virus type 3 and establishment of indirect ELISA antibody detection method. | 2017 | 2 |
| 20 | UTILIZATION OF CHOLINE IN DIFFERENT LEVELS AND DIETARY CHOLINE AVAILABILITY VALUES IN SEVEN COMMON FEED INGREDIENTS FOR JUVENILE BLUNT SNOUT BREAM, MEGALOBRAMA AMBLYCEPHALA | 2014 | 1 |
About Mi Wang
Mi Wang is a scholar working on Animal Science and Zoology, Small Animals, Metals and Alloys, Hematology and Critical Care and Intensive Care Medicine, having authored 206 papers that have together received 6.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (23 papers), Ubiquitin and proteasome pathways (17 papers), Peptidase Inhibition and Analysis (13 papers), Veterinary medicine and infectious diseases (12 papers), Coccidia and coccidiosis research (12 papers), Multiple Myeloma Research and Treatments (11 papers), Nuclear Materials and Properties (8 papers) and Synthesis and Biological Evaluation (8 papers). The work is most often cited by research in Pharmaceutical Science (444 citations), Hematology (591 citations), Molecular Biology (3.0k citations), Oncology (1.1k citations) and Immunology (600 citations). Mi Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Shaomeng Wang, Chao‐Yie Yang, Jeanne A. Stuckey, Krishnapriya Chinnaswamy, Weisan Pan, Donna McEachern, Ning Li, Liu Liu, Xin Han and Miao Song. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Colloid and Interface Science, Frontiers in Psychiatry, Journal of Nuclear Materials and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.